Xiuli Guo
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 5%
- Galectins and Cancer Biology
Papers in
-
- Glycosylation and Glycoproteins Research 5
- Metabolism, Diabetes, and Cancer 5
- Angiogenesis and VEGF in Cancer 4
-
- MicroRNA in disease regulation 8
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Lu‐Gang Yu (18 shared papers)Zhan‐Qi Cao (5 shared papers)Qicheng Zhao (4 shared papers)Jonathan M. Rhodes (4 shared papers)Xiaoxia Yang (6 shared papers)Huihui Zhang (3 shared papers)Lei Wang (2 shared papers)Chao Sun (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (7 papers)Life Sciences (4 papers)Molecular Pharmaceutics (3 papers)Acta Pharmacologica Sinica (3 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- ChinaUnited KingdomAustralia
In The Last Decade
Xiuli Guo
80 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 513
- Immunology 662
- Molecular Biology 1.6k
- Oncology 489
- Toxicology 40
Countries citing papers authored by Xiuli Guo
This map shows the geographic impact of Xiuli Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuli Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuli Guo more than expected).
Fields of papers citing papers by Xiuli Guo
This network shows the impact of papers produced by Xiuli Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuli Guo. The network helps show where Xiuli Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiuli Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 189 | |
| 2 | 2012 | 187 | |
| 3 | 2010 | 179 | |
| 4 | 2011 | 140 | |
| 5 | 2009 | 138 | |
| 6 | 2016 | 112 | |
| 7 | 2017 | 93 | |
| 8 | 2017 | 81 | |
| 9 | [Tumor stem cells and drug resistance]. | 2007 | 81 |
| 10 | 2016 | 78 | |
| 11 | 2016 | 75 | |
| 12 | 2016 | 73 | |
| 13 | 2014 | 68 | |
| 14 | 2017 | 54 | |
| 15 | 2020 | 51 | |
| 16 | 2018 | 49 | |
| 17 | 2017 | 47 | |
| 18 | 2019 | 44 | |
| 19 | 2021 | 40 | |
| 20 | 2012 | 38 |
About Xiuli Guo
Xiuli Guo is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Pharmacology, having authored 82 papers that have together received 2.7k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (12 papers), MicroRNA in disease regulation (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Glycosylation and Glycoproteins Research (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Traditional Chinese Medicine Analysis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (513 citations), Immunology (662 citations), Molecular Biology (1.6k citations), Oncology (489 citations) and Toxicology (40 citations). Xiuli Guo has collaborated with scholars based in China, United Kingdom and Australia. Frequent co-authors include Lu‐Gang Yu, Zhan‐Qi Cao, Qicheng Zhao, Jonathan M. Rhodes, Xiaoxia Yang, Huihui Zhang, Lei Wang, Chao Sun, John Hilkens and Yanna Cheng. Their work appears in journals such as Biomedicine & Pharmacotherapy, Life Sciences, Molecular Pharmaceutics, Acta Pharmacologica Sinica and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.